ACE inhibitor intolerance and lessons learned from the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) trials.
about
ACE inhibitor intolerance and lessons learned from the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) trials.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
ACE inhibitor intolerance and ...... and morbidity (CHARM) trials.
@en
ACE inhibitor intolerance and ...... ion in mortality and morbidity
@nl
type
label
ACE inhibitor intolerance and ...... and morbidity (CHARM) trials.
@en
ACE inhibitor intolerance and ...... ion in mortality and morbidity
@nl
prefLabel
ACE inhibitor intolerance and ...... and morbidity (CHARM) trials.
@en
ACE inhibitor intolerance and ...... ion in mortality and morbidity
@nl
P2860
P1476
ACE inhibitor intolerance and ...... and morbidity (CHARM) trials.
@en
P2093
Domenic A Sica
P2860
P304
P356
10.1111/J.1527-5299.2004.02806.X
P577
2004-05-01T00:00:00Z